Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report.

BMC cancer - 6 Jan 2017

Namløs Heidi M, Zaikova Olga, Bjerkehagen Bodil, Vodák Daniel, Hovig Eivind, Myklebost Ola, Boye Kjetil, Meza-Zepeda Leonardo A

Abstract excerpt

BACKGROUND: Many patients experience local recurrence or metastases after receiving potentially curative treatment, and early detection of these events is important for disease control. Recent technological advances make it possible to use blood plasma containing circulating cell-free tumour DNA (ctDNA) as a liquid biopsy. In this case report we show how serial liquid biopsies can be used to monitor the disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Progression
Share to DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to KRAS gene

Share to Liquid Biopsy

Share to Mutation

Share to Neoplasm Recurrence, Local

Share to Sarcoma

Source

Open in PubMed Open full text

Identifiers

PMID: 28061772
DOI: 10.1186/s12885-016-2992-8
PMCID: PMC5219677

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report.PMID 28061772Read ↗

Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.Semantic proximity Read ↗

The Circulating Nucleic Acid Characteristics of Non-Metastatic Soft Tissue Sarcoma Patients.Semantic proximity Read ↗

Unlocking the Potential of ctDNA in Sarcomas: A Review of Recent AdvancesSemantic proximity Read ↗

Prognostic potential of fusion gene analysis using plasma cell-free RNA in malignant bone and soft tissue tumoursSemantic proximity Read ↗

Genotyping of Circulating Free DNA Enables Monitoring of Tumor Dynamics in Synovial SarcomasSemantic proximity Read ↗

Individualized Mini-Panel Sequencing of ctDNA Allows Tumor Monitoring in Complex Karyotype Sarcomas.Semantic proximity Read ↗

Circulating tumour-derived DNA in metastatic soft tissue sarcomaSemantic proximity Read ↗

Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNASemantic proximity Read ↗

Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer.Semantic proximity Read ↗

Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft‐tissue sarcomasSemantic proximity Read ↗

Sensitive Detection of Gynecological Cancer Recurrence Using Circulating Tumor DNA and Digital PCR: A Comparative Study with Serum Biochemical Markers.Semantic proximity Read ↗

The Use of Liquid Biopsy in the Molecular Analysis of Plasma Compared to the Tumour Tissue from a Patient with Brain Metastasis: A Case Report.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.